The Form 4 filing, a public report of insider share activity, was filed on November 17, 2026. The purchase took place on November 13, 2026, four days before the filing date.
The report lists RA Capital Management, L.P. as a director and 10% owner of PepGen (PEPG). PepGen is listed in the healthcare sector and biotechnology industry.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-13 |
| Date of Latest Transaction | 2026-11-13 |
| Buy/Sell | buy |
| Transaction Count | 1 |
| Shares Transacted | 8,625,000 |
| Price | $5.00 |
| Total Transaction Value | $43,125,000.00 |
| Insider | |
| Ticker Symbol | PEPG |
| Company | PepGen Inc. |
| Insider Name | RA CAPITAL MANAGEMENT, L.P. |
| Insider Title | Director, 10% Owner |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 27,179,273 |
| Position Size Change | 31.73% |
| Filing | |
| Filing Date | 2026-11-17 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share purchase reported under transaction code P. The filing lists one purchase transaction. The available details do not say whether it took place on the open market or through a private deal.
What was the average price of the transaction?
The reported average price was $5.00 per share for the November 13 purchase.
How did this transaction affect the insider's holdings?
The purchase added 8,625,000 shares to the reported holdings. RA Capital Management, L.P. reported 27,179,273 shares owned afterward. The shares bought made up 31.73% of that total.
What's the total transaction value?
The total transaction value was $43,125,000.00. This amount covers the one reported purchase.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnote text is not available here, so further details about the purchase terms remain unknown.
For research purposes only; not investment advice.